Despite increased scrutiny from legislators and clinicians, private equity investors are expected to fuel continued growth and consolidation in the dental industry, according to Geith Kallas, DDS.
Dr. Kallas is the CEO of Smile Makers Dental Center in Tyson’s Corner, Va. He recently spoke with Becker’s about private equity’s growing role in dentistry.
Editor’s note: This response was lightly edited for length and clarity.
Question: How do you think private equity will influence dentistry in 2026? What role will PE play in dental M&A this year?
Dr. Geith Kallas: Private equity is expected to continue shaping the dental industry in 2026, with a focus on consolidation and growth. I anticipate PE firms will play a significant role in dental M&A, driving deals and investments in the sector.
– Consolidation: PE firms will continue to consolidate dentistry, with smaller firms merging into larger, more established organizations.
– Operational improvement: PE groups are shifting from rapid roll-ups to operational improvement, focusing on scheduling optimization, centralized revenue cycle management and digital workflow improvements.
– Growth equity: Growth equity funds will provide capital for expansion, bridging innovation from startups to scale-ready companies.
– Regulatory scrutiny: Increased regulatory scrutiny is expected, with governments tightening rules to protect investors and ensure stability.
PE’s role in dental M&A:
– Investments: PE firms will invest in DSOs, fueling growth and network expansion.
– M&A activity: PE firms will drive dental M&A, with a focus on strategic acquisitions and partnerships.
